Please enable JavaScript to continue using this application.

Compare $ALXO vs $CNTN | Chartloom

Compare

$ALXO vs $CNTN

ALX Oncology Holdings Inc · Canton Strategic Holdings Inc

ALXO

ALX Oncology Holdings Inc

CNTN

Canton Strategic Holdings Inc

Compare $ALXO vs $CNTN

Comparing ALX Oncology Holdings Inc and Canton Strategic Holdings Inc

ALXOALX Oncology Holdings Inc

CNTNCanton Strategic Holdings Inc

ALXOALX Oncology Holdings Inc

Market cap

$168M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

8.7%

52W performance

-36.5%

FCF yield

-42.2%

CNTNCanton Strategic Holdings Inc

Market cap

$163M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-37.6%

52W performance

-33.6%

FCF yield

-97.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALXO

CNTN

Detailed metrics comparison

ALXO

ALX Oncology Holdings Inc

CNTN

Canton Strategic Holdings Inc

Market Cap

ALXO$168M

CNTN$163M

Enterprise Value

ALXO$156M

CNTN$125M

Price

ALXO$1.25

CNTN$2.11

P/E Ratio

ALXON/A

CNTNN/A

P/S Ratio

ALXO46.09x

CNTN108.78x

EV/Sales

ALXO0.00x

CNTN83.88x

EV/EBITDA

ALXO0.00x

CNTN0.00x

P/B Ratio

ALXO1.24x

CNTN0.39x

P/FCF Ratio

ALXON/A

CNTNN/A

EV/FCF

ALXO-2.20x

CNTN-0.79x

PEG Ratio

ALXON/A

CNTNN/A

Forward P/E (NTM)

ALXON/A

CNTNN/A

Forward P/S (NTM)

ALXON/A

CNTNN/A

Revenue (TTM)

ALXO$0

CNTN$1M

Revenue Growth (YoY)

ALXON/A

CNTNN/A

Forward Rev Growth

ALXO357.6%

CNTN0.0%

Gross Margin (TTM)

ALXO9.0%

CNTN0.0%

Operating Margin (TTM)

ALXO0.0%

CNTN0.0%

EBITDA Margin (TTM)

ALXO0.0%

CNTN-1120.1%

Net Margin (TTM)

ALXO0.0%

CNTN-6559.1%

FCF Margin (TTM)

ALXON/A

CNTN-10651.0%

Net Income (TTM)

ALXO$-81M

CNTN$-98M

FCF (TTM)

ALXO$-71M

CNTN$-159M

EPS (TTM)

ALXO-$0.60

CNTN-$0.45

ROE (TTM)

ALXO-9030.0%

CNTN-2954.0%

ROA (TTM)

ALXO-6728.0%

CNTN-2342.0%

ROIC (TTM)

ALXO-8046.0%

CNTN-2953.0%

Cash

ALXO$23M

CNTN$37M

Debt

ALXO$11M

CNTN$0

Net Cash/Debt

ALXO$12M

CNTN$37M

Current Ratio (TTM)

ALXO9.71x

CNTN15.70x

Quick Ratio (TTM)

ALXO9.44x

CNTN14.45x

Debt/Equity (TTM)

ALXO0.08x

CNTN0.00x

Debt/Assets (TTM)

ALXO0.0%

CNTN0.0%

Interest Coverage (TTM)

ALXON/A

CNTNN/A

Net Debt/EBITDA (TTM)

ALXO0.00x

CNTN0.00x

Beta

ALXO0.55

CNTN1.52

52W Performance

ALXO-36.5%

CNTN-33.6%

YTD Performance

ALXO8.7%

CNTN-37.6%

% from 52W High

ALXO-53.0%

CNTN-69.4%

% from 52W Low

ALXO19.0%

CNTN20.6%

Asset Turnover (TTM)

ALXO0.00x

CNTN0.00x

FCF Yield (TTM)

ALXO-42.2%

CNTN-97.9%

Earnings Yield (TTM)

ALXO-48.1%

CNTN-60.3%

Dividend Yield (TTM)

ALXON/A

CNTNN/A

Rule of 40

ALXO0.0

CNTN-10,651.0

EV/GP/RG

ALXON/A

CNTNN/A

Ticker research

View ALXO research View CNTN research

Metric	ALXO ALX Oncology Holdings Inc	CNTN Canton Strategic Holdings Inc
Market & Valuation
Market Cap	$168M	$163M
Enterprise Value	$156M	$125M
Price	$1.25	$2.11
P/E Ratio	N/A	N/A
P/S Ratio	46.09x	108.78x
EV/Sales	0.00x	83.88x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.24x	0.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.20x	-0.79x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	357.6%	0.0%
Profitability
Gross Margin (TTM)	9.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1120.1%
Net Margin (TTM)	0.0%	-6559.1%
FCF Margin (TTM)	N/A	-10651.0%
Net Income (TTM)	$-81M	$-98M
FCF (TTM)	$-71M	$-159M
EPS (TTM)	-$0.60	-$0.45
ROE (TTM)	-9030.0%	-2954.0%
ROA (TTM)	-6728.0%	-2342.0%
ROIC (TTM)	-8046.0%	-2953.0%
Financial Health
Cash	$23M	$37M
Debt	$11M	$0
Net Cash/Debt	$12M	$37M
Current Ratio (TTM)	9.71x	15.70x
Quick Ratio (TTM)	9.44x	14.45x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.55	1.52
52W Performance	-36.5%	-33.6%
YTD Performance	8.7%	-37.6%
% from 52W High	-53.0%	-69.4%
% from 52W Low	19.0%	20.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-42.2%	-97.9%
Earnings Yield (TTM)	-48.1%	-60.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-10,651.0
EV/GP/RG	N/A	N/A
Ticker research	View ALXO research	View CNTN research

Valuation

P/S Ratio

ALXO

46.09x

CNTN

108.78x

EV/FCF

ALXO

-2.20x

CNTN

-0.79x

Growth & revenue

Forward Revenue Growth

ALXO

357.6%

CNTN

0.0%

Profitability & performance

Gross Margin

ALXO

9.0%

CNTN

0.0%

ROE

CNTN

-2954.0%

ALXO

-9030.0%

FCF Yield %

ALXO

-42.2%

CNTN

-97.9%

52-Week Performance

CNTN

-33.6%

ALXO

-36.5%

Detailed metrics comparison

ALXO

ALX Oncology Holdings Inc

CNTN

Canton Strategic Holdings Inc

Market Cap

ALXO$168M

CNTN$163M

Enterprise Value

ALXO$156M

CNTN$125M

Price

ALXO$1.25

CNTN$2.11

P/E Ratio

ALXON/A

CNTNN/A

P/S Ratio

ALXO46.09x

CNTN108.78x

EV/Sales

ALXO0.00x

CNTN83.88x

EV/EBITDA

ALXO0.00x

CNTN0.00x

P/B Ratio

ALXO1.24x

CNTN0.39x

P/FCF Ratio

ALXON/A

CNTNN/A

EV/FCF

ALXO-2.20x

CNTN-0.79x

PEG Ratio

ALXON/A

CNTNN/A

Forward P/E (NTM)

ALXON/A

CNTNN/A

Forward P/S (NTM)

ALXON/A

CNTNN/A

Revenue (TTM)

ALXO$0

CNTN$1M

Revenue Growth (YoY)

ALXON/A

CNTNN/A

Forward Rev Growth

ALXO357.6%

CNTN0.0%

Gross Margin (TTM)

ALXO9.0%

CNTN0.0%

Operating Margin (TTM)

ALXO0.0%

CNTN0.0%

EBITDA Margin (TTM)

ALXO0.0%

CNTN-1120.1%

Net Margin (TTM)

ALXO0.0%

CNTN-6559.1%

FCF Margin (TTM)

ALXON/A

CNTN-10651.0%

Net Income (TTM)

ALXO$-81M

CNTN$-98M

FCF (TTM)

ALXO$-71M

CNTN$-159M

EPS (TTM)

ALXO-$0.60

CNTN-$0.45

ROE (TTM)

ALXO-9030.0%

CNTN-2954.0%

ROA (TTM)

ALXO-6728.0%

CNTN-2342.0%

ROIC (TTM)

ALXO-8046.0%

CNTN-2953.0%

Cash

ALXO$23M

CNTN$37M

Debt

ALXO$11M

CNTN$0

Net Cash/Debt

ALXO$12M

CNTN$37M

Current Ratio (TTM)

ALXO9.71x

CNTN15.70x

Quick Ratio (TTM)

ALXO9.44x

CNTN14.45x

Debt/Equity (TTM)

ALXO0.08x

CNTN0.00x

Debt/Assets (TTM)

ALXO0.0%

CNTN0.0%

Interest Coverage (TTM)

ALXON/A

CNTNN/A

Net Debt/EBITDA (TTM)

ALXO0.00x

CNTN0.00x

Beta

ALXO0.55

CNTN1.52

52W Performance

ALXO-36.5%

CNTN-33.6%

YTD Performance

ALXO8.7%

CNTN-37.6%

% from 52W High

ALXO-53.0%

CNTN-69.4%

% from 52W Low

ALXO19.0%

CNTN20.6%

Asset Turnover (TTM)

ALXO0.00x

CNTN0.00x

FCF Yield (TTM)

ALXO-42.2%

CNTN-97.9%

Earnings Yield (TTM)

ALXO-48.1%

CNTN-60.3%

Dividend Yield (TTM)

ALXON/A

CNTNN/A

Rule of 40

ALXO0.0

CNTN-10,651.0

EV/GP/RG

ALXON/A

CNTNN/A

Ticker research

View ALXO research View CNTN research

Metric	ALXO ALX Oncology Holdings Inc	CNTN Canton Strategic Holdings Inc
Market & Valuation
Market Cap	$168M	$163M
Enterprise Value	$156M	$125M
Price	$1.25	$2.11
P/E Ratio	N/A	N/A
P/S Ratio	46.09x	108.78x
EV/Sales	0.00x	83.88x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.24x	0.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.20x	-0.79x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	357.6%	0.0%
Profitability
Gross Margin (TTM)	9.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1120.1%
Net Margin (TTM)	0.0%	-6559.1%
FCF Margin (TTM)	N/A	-10651.0%
Net Income (TTM)	$-81M	$-98M
FCF (TTM)	$-71M	$-159M
EPS (TTM)	-$0.60	-$0.45
ROE (TTM)	-9030.0%	-2954.0%
ROA (TTM)	-6728.0%	-2342.0%
ROIC (TTM)	-8046.0%	-2953.0%
Financial Health
Cash	$23M	$37M
Debt	$11M	$0
Net Cash/Debt	$12M	$37M
Current Ratio (TTM)	9.71x	15.70x
Quick Ratio (TTM)	9.44x	14.45x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.55	1.52
52W Performance	-36.5%	-33.6%
YTD Performance	8.7%	-37.6%
% from 52W High	-53.0%	-69.4%
% from 52W Low	19.0%	20.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-42.2%	-97.9%
Earnings Yield (TTM)	-48.1%	-60.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-10,651.0
EV/GP/RG	N/A	N/A
Ticker research	View ALXO research	View CNTN research